The company’s stock dropped after details of a study raised questions about how widely the treatment would be used.

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according ...

Researchers ran five models through Claude Code, OpenCode and mini-SWE-agent. Swapping harnesses changed scores no more than ...

The Proposal has spent over 70 days on Apple TV’s global charts. It’s currently in eighth place on the global top 10 list, ...

Over the years, actor Jason Statham has built a solid fan base with numerous action roles. He is celebrated worldwide for his ...

Visa quotas, university fees and NHS surcharges remain sticking points ahead of post-Brexit negotiations next month ...

It’s another salvo in a fight for public support, the data center developer has undertaken to try and change an increasingly ...

Lav Kush Prasad who belonged from a small village in Bihar overcame all odds and secured a job as Scientist in ISRO. Know his ...

Moderna and Merck's personalized mRNA vaccine raised two-year recurrence-free survival to 82.2%, from 70% with Keytruda alone ...

Completion of light dose-escalation Part A of Phase 1 study identifies regimen for further evaluation in Part B, supporting advancement of Padeliporfin VTP for treatment of locally advanced pancreatic ...

A new study from Ramp and Revelio Labs offers valuable evidence about how companies behave after investing heavily in ...

Receiving an autism diagnosis later in life brings up complex emotions. For those with eating disorders, it could be the key ...